Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Farmacéutica Paraguaya S.A. (FAPASA) is a leading pharmaceutical company based in Paraguay and a core manufacturing and commercial hub for the Adium Group. The company specializes in the production, marketing, and distribution of a broad portfolio of pharmaceutical products, including high-quality generics and licensed brands from global partners. FAPASA operates advanced manufacturing facilities that are certified under international Good Manufacturing Practices (GMP), enabling it to serve as a major exporter to markets across Latin America. Its therapeutic focus spans critical areas such as cardiology, oncology, neurology, and endocrinology. As a strategic regional player, FAPASA facilitates the introduction of innovative therapies into the Paraguayan and broader South American markets through robust commercial and regulatory capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Farmaceutica Paraguay.